Navegar

Colección

Datos Estadísticas

Lista de

neramexane
8
"Pharmacological approaches to tinnitus treatment" (2011) Elgoyhen, A.B.; Langguth, B. Textbook of Tinnitus:625-637
"Emerging pharmacotherapy of tinnitus" (2011) Langguth, B.; Elgoyhen, A.B. Expert Opinion on Emerging Drugs. 16(4):603-606
"Pharmacological approaches to the treatment of tinnitus" (2010) Elgoyhen, A.B.; Langguth, B. Drug Discovery Today. 15(7-8):300-305
"The nicotinic receptor of cochlear hair cells: A possible pharmacotherapeutic target?" (2009) Elgoyhen, A.B.; Katz, E.; Fuchs, P.A. Biochemical Pharmacology. 78(7):712-719
"Emerging pharmacotherapy of tinnitus" (2009) Langguth, B.; Salvi, R.; Elgoyhen, A.B. Expert Opinion on Emerging Drugs. 14(4):687-702
"Inhibition of the α9α10 nicotinic cholinergic receptor by neramexane, an open channel blocker of N-methyl-d-aspartate receptors" (2007) Plazas, P.V.;Savino, J.;Kracun, S. (...)Elgoyhen, A.B. European Journal of Pharmacology. 566(1-3):11-19
"Inhibition of the α9α10 nicotinic cholinergic receptor by neramexane, an open channel blocker of N-methyl-d-aspartate receptors" (2007) Plazas, P.V.;Savino, J.;Kracun, S. (...)Elgoyhen, A.B. European Journal of Pharmacology. 566(1-3):11-19
"Inhibition of the α9α10 nicotinic cholinergic receptor by neramexane, an open channel blocker of N-methyl-d-aspartate receptors" (2007) Plazas, P.V.;Savino, J.;Kracun, S. (...)Elgoyhen, A.B. European Journal of Pharmacology. 566(1-3):11-19